July 30, 2022, 3 p.m. | Julia Kollewe

Artificial intelligence (AI) | The Guardian www.theguardian.com

The British scientist’s company employs artificial intelligence to drastically reduce the speed of drug development

It was early one morning in 1996 when Andrew Hopkins, then a PhD biophysics student at Oxford University, had a brainwave as he walked home from a late-night lab meeting.

He was trying to find molecules to fight HIV and to better understand drug resistance.

Continue reading...

ai artificial intelligence (ai) business computing cure disease entrepreneurs human biology pharmaceuticals industry small business technology

More from www.theguardian.com / Artificial intelligence (AI) | The Guardian

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US